RACK1 and breast carcinoma: Li et al. reported that the express of RHBDF1 inhibited the RACK1 induced HIF-α degradation in breast cancer, which aggravated the hypoxic environment of the tumor environment and promoted the activation of the glycolysis pathway (Zhou et al., 2014).